Genistein and daidzein decrease food intake and body weight gain in mice, and alter LXR signaling in vivo and in...

Area of Science:

• Nutritional Science
• Metabolic Health
• Molecular Biology

Background:

• Metabolic syndrome is a growing health concern.
• Soy isoflavones, like genistein and daidzein, are plant compounds with potential health benefits.
• The role of soy isoflavones in metabolic regulation and their interaction with Liver X Receptor (LXR) pathways require further investigation.

Purpose of the Study:

• To determine if soy isoflavones, genistein and daidzein, differentially affect metabolic syndrome.
• To investigate the involvement of Liver X Receptor (LXR) regulation in the effects of these isoflavones.

Main Methods:

• C57BL/6J mice were fed a low-fat diet, a western-style diet (WD), or WD supplemented with genistein or daidzein for 10 weeks.
• Body weight gain, energy intake, and glucose tolerance were assessed.
• Hepatic mRNA gene array profiling and cell-based studies (HepG2, mouse embryonic fibroblasts) were used to examine LXR pathway involvement.

Main Results:

• Both genistein and daidzein significantly reduced body weight gain and energy intake compared to the western-style diet alone.
• Genistein demonstrated a more pronounced reduction in body weight gain and food intake than daidzein.
• Genistein consumption significantly improved glucose tolerance.
• Gene expression analysis and cell studies indicated that both genistein and daidzein activate LXR-mediated pathways.

Conclusions:

• Soy isoflavones, particularly genistein, can mitigate adverse effects of a western-style diet in mice.
• Genistein and daidzein exert their effects, at least partly, through the regulation of LXR-mediated pathways.
• Dietary interventions with soy isoflavones may offer a strategy for managing metabolic syndrome.